Nektar Therapeutics
Price & Volume
Stats
See more52W Range | $7.99-$78.95 |
Market Cap | $2.2B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $55.2M |
Revenue Growth (YoY) | -25.3% |
Gross Profit (12 Mos) | $55.2M |
Diluted EPS | -$9.73 |
News
See moreYahoo Finance • 11 hours ago
NKTR Investor Alert: Nektar Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misleading Institutional Shareholders: Levi & Korsinsky
Yahoo Finance • yesterday
ROSEN, A LEADING AND RANKED FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR
About
CEO | Mr. Howard W. Robin |
Address | 455 Mission Bay Boulevard South, San Francisco, CA, United States, 94158 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 63 |
